Morphea - I-Morphea
☆ AI Dermatology — Free Service
Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Isilonda le-Morphea (Morphea) ngokuvamile sivela njengesichibi esinemibala e-atrophic.
relevance score : -100.0%
ReferencesI-scleroderma yisifo esingavamile esithinta izicubu ezixhumeneyo, esibonakala njengesikhumba esiqinile futhi kwesinye isikhathi sithinta ezinye izingxenye zomzimba. Kunezinhlobo ezimbili eziyinhloko: i-systemic sclerosis, ezibandakanya ukuqina kwesikhumba nezitho zangaphakathi, kanye ne-localized scleroderma, eyaziwa nangokuthi i-morphea, ehlala ikhawulelwe esikhumbeni nasemathunjini angaphansi kwayo, enokuma okuhle futhi enezinhlaka ezincane. Nakuba i-localized scleroderma ingavamile futhi imbangela yayo ingacacile, ucwaningo lwakamuva lubonisa ukuthi ingathinta nezitho zangaphakathi futhi iholele ezinkingeni ezihlukahlukene zezempilo. Ukwelashwa kusenesikhathi kubalulekile ukuze kuvinjelwe izinkinga, ikakhulukazi uma kubhekwa ubucayi obungaba khona be-localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea, eyaziwa nangokuthi i-localized scleroderma, yisifo esingajwayelekile sokuzivikela komzimba esithinta izicubu ezixhumeneyo. Ingavela ngezindlela ezihlukene, futhi ayijwayelekile kakhulu, cishe amacala angu‑0.4–2.7 kubantu abangu‑100 000 ngonyaka. Morphea ivame ukubonakala ezinganeni ezineminyaka engu‑2 kuya kwengu‑14, futhi ivame ukuthinta amantombazane kunabafana.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
I-Morphea yisifo esingavamile kakhulu. Ngenxa yokwakheka kwesithombe, i-algorithm ingase yenze iphutha ngokuthi i-morphea (morphea).